U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089043) titled 'A Study in Subjects With Neurogenic Orthostatic Hypotension' on July 14.
Brief Summary: This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).
Study Start Date: Sept. 08
Study Type: INTERVENTIONAL
Condition:
Neurogenic Orthostatic Hypotension
Intervention:
DRUG: CST-3056
Administered as an oral solution
DRUG: Placebo
Administered as an oral solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: CuraSen Therapeutics, Inc.
Disclaimer: Curated by HT Syndication....